Ra Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ra Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ra Pharmaceuticals Inc Strategy Report
- Understand Ra Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Ra Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 23 Dec 2019 | Ra Pharmaceuticals Inc Enters Phase III Clinical Trial Agreement with A2 Healthcare Corp for zilucoplan (GDCT0370715) | Contract Service Agreement |
Ra Pharmaceuticals Inc
Ra Pharmaceuticals Inc |
A2 Healthcare Corp
A2 Healthcare Corp
|
| 10 Oct 2019 | UCB Acquires Ra Pharma | Acquisition |
UCB SA
|
Ra Pharmaceuticals Inc |
| 22 Jul 2019 | Ra Pharma Raises USD149.5 Million in Public Offering of Shares | Equity Offering | - |
Ra Pharmaceuticals Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer